Organization: Brain Canada

The Short Report – Dec. 22, 2021: Trudeau releases mandate letters, a promising brain diseases partnership, a national survey of young people’s attitudes towards science, and more

A new Quebec neuroscience partnership may advance drug discovery for brain diseases through AI and Open Science; a CFI national survey shows most young adults have confidence in science; Dr. Leah Cowen has been named the University of Toronto’s vice-president, research and innovation, and strategic initiatives, and more.

The Short Report – April 14, 2021: Alberta invests in vaccine R&D, Ottawa brings wireless tech to mining industry, CIB shores up Ontario’s energy grid, and more

In this week’s The Short Report, the Government of Alberta contributes $20 million for vaccine R&D, a Canadian Infrastructure Bank invests in Ontario’s energy grid, 5G wireless tech to increase safety and reliability in the mining industry, Palette Skills leads consortium to address talent gaps in a post-COVID economy, and more.

Brain Canada & CQDM fund AbCellera’s cell screening platform technology

AbCellera Biologics Inc and the Univ of British Columbia (UBC) received non-dilutive funding of $1 million from pharma-based consortium CQDM and charitable organization Brain Canada Foundation to advance a discovery platform for next-generation antibody therapeutics. With the additional contribution of $450,000 from AbCellera, the program will leverage AbCellera’s high throughput, single-cell screening platform to allow rapid…

Six neuroscience teams awarded $8.5 million

CQDM (a Centre of Excellence for Commercialization and Research), Brain Canada and the Ontario Brain Institute have awarded nearly $8.5 million — augmented by $1.5 million in in-kind contributions — to six multi-provincial research teams. The investment will see 33 researchers from academia partnering with smaller companies to develop tools, technologies and platforms that accelerate…

New stroke drug receives $6.6 million for clinical trials

A new drug designed to contain damage resulting from a stroke will go to Phase III clinical trials with a $6.6-million donation from Brain Canada and its matching fund partners. The clinical trials, dubbed FRONTIER, will cost $10 million and will be conducted by

OBI contributed $2.5M to Focus on Brain initiative

The Ontario Brain Institute (OBI) has announced a $2.5-million contribution to the Focus on Brain initiative recently launched by the Quebec Consortium for Drug Discovery (CQDM) and Brain Canada (R$, June 16/14). The initiative now has $12.5 million to invest in applied R&D neuroscience projects, with OBI funding devoted to projects with Ontario participation. The…

FedDev contributes $11 million to brain research

The Ontario Brain Institute (OBI) has received $11 million from the federal government to support 14 projects, leveraging an equal amount from the private sector. The funding comes from the Technology Development Program of the Federal Economic Development Agency for Southern Ontario (FedDev Ontario). The funded projects involve 12 not-for-profit organizations, 11 companies based in…